Corneal endothelial cells often adopt a fibroblastic-like morphology in culture, a process that has been attributed to epithelial-or endothelial-to-mesenchymal transition (EMT or EndMT). Although being extensively studied in other cell types, this transition is less well characterized in the corneal endothelium. Because of their neuroectodermal origin and their in vivo mitotic arrest, corneal endothelial cells represent a particular tissue that deserves more attention. This review article presents the basic principles underlying EMT/EndMT, with emphasis on the current knowledge regarding the corneal endothelium. Furthermore, this review discusses cell culture conditions and major cell signaling pathways that have been identified as EndMT-triggering factors. Finally, it summarizes strategies that have been developed to inhibit EndMT in corneal endothelial cell culture. The review of current studies on corneal and classical EndMT highlights some research avenues to pursue in the future and underscores the need to extend our knowledge of this process in order to optimize usage of these cells in regenerative medicine.
T he corneal endothelium is a monolayer of hexagonal cells located on the posterior surface of the cornea, lying on a specialized basement membrane called Descemet's membrane. It acts as a leaky barrier between the corneal stroma and the aqueous humor of the anterior chamber. The corneal stroma has a natural tendency to imbibe fluid from the anterior chamber; however, stromal edema decreases corneal transparency. The main role of the corneal endothelium is to regulate stromal hydration by pumping excess fluids out of the stroma, which is achieved through ionic pumps and cotransporters. 1 Thus, the corneal endothelium is responsible for the maintenance of corneal transparency by controlling stromal deturgescence through a ''pump-leak'' mechanism.
In vivo, human corneal endothelial cells (CECs) are arrested in the G1 phase of the cell cycle 2 and thus remain in a nonproliferative state. A high endothelial cell density is necessary in order to maintain their pump-leak equilibrium. 3 When endothelial density diminishes to under a critical value (around 400-700 cells/mm 2 ) 4 following diseases or injury, the normal barrier and pump functions of the endothelium are no longer sufficient to maintain the transparency of the cornea. This irreversible decompensation results in corneal edema and vision loss. To this day, the only way to restore vision after endothelial decompensation is to replace the endothelium with an allogeneic graft by either penetrating keratoplasty or endothelial keratoplasty. Endothelial dysfunction represented the first indication for corneal transplantation in the United States as 26,509 procedures (40% of all transplantations) were performed in 2013. 5 For many years researchers have turned toward the use of cultured CECs as an alternative for the replacement of the corneal endothelium. [6] [7] [8] Even though CECs are in a nonproliferative state in vivo, they still possess regenerative capacities and can be expanded in vitro. 9 It has been demonstrated that disruption of cell contacts and addition of growth factors to the culture medium stimulate replication of CECs. Specific culture media have been developed for human, 10 porcine, 11 and feline 12 endothelial cells. They combine a variety of supplements such as insulin, growth factors (nerve growth factor [NGF] , epithelial growth factor [EGF] , fibroblast growth factor [FGF] ), bovine pituitary extract (BPE), ascorbic acid, serum, and various cytokines and mitogens, all aimed at increasing cell proliferation. The use of pharmacologic inhibitors of Rho-kinase (ROCK) and type I TGFb receptor (TbRI) as well as a medium conditioned by mesenchymal stem cells or irradiated 3T3 cells was also reported. 13, 14 However, cell culture of CECs can result in a phenotypic switch that changes their morphology from endothelial to fibroblastic. [15] [16] [17] [18] Endothelial-to-mesenchymal transition (EndMT), a variant of the well-known epithelial-tomesenchymal transition (EMT), 19, 20 has been postulated to play 
EPITHELIAL-AND ENDOTHELIAL-TO-MESENCHYMAL TRANSITION
The EMT or EndMT, in a few words, is the process by which epithelial or endothelial cells lose their specific markers and acquire mesenchymal characteristics. The EMT was first described in the early 1980s by Elizabeth Hay, who observed this phenomenon in the primitive streak of chick embryos. The authors were able to recapitulate this process in vitro using collagen gels. 22, 23 This transition was then shown to play an important role in normal physiological processes such as embryonic development, wound healing, and stem cell behavior. However, EMT is also implicated in pathologic processes such as fibrosis and cancer. 24, 25 The EMT and EndMT are characterized by key events that are either causes or consequences of the transition. Those include the disassembly of cell-cell junctions, loss of apical-basal polarity, actin cytoskeleton reorganization, changes in cell shape, increased cell motility, increase in the production of extracellular matrix proteins, and changes in gene expression. Cells can also acquire extracellular matrix (ECM) degradation capabilities (expression of matrix metalloproteinase [MMP-2 and MMP-9]) as well as resistance to apoptosis and senescence. 19 Studies in cancer and other cell types, mostly of epithelial nature, have provided insight on how classical EMT occurs (extensively reviewed in Ref. 19 ). 19, 20 The EndMT has been studied on vascular endothelial cells. [26] [27] [28] However, the corneal endothelium, a transporting endothelium of neuroectodermal origin, is distinct from both the epithelium and the vascular endothelium. Thus, the loss of corneal endothelial phenotype following cell culture may be specific to this structure and regulated by different mechanisms, and deserves particular attention.
CELL JUNCTION DESTABILIZATION AND LOSS OF APICAL-BASAL POLARITY
Epithelia and endothelia act as selective barriers between two compartments, for either protection (e.g., epidermis), secretion (gland), absorption (intestine), or selective exchange (endothelium). This barrier function is dependent upon the capability of the cells to regulate passage of certain substances from one compartment to the other. This would not be possible without cells being tightly bound together by numerous tight and adherens junctions. Tight junctions, composed of claudins and occludins, seal the gap between cells and connect to the cytoskeleton with the help of membrane-associated proteins such as zonula occludens (ZO)-1. 29 Adherens junctions also play a vital role in barrier function by holding cells together into a cohesive epithelium. These junctions are formed by epithelial cadherin (E-cadherin) that binds adjacent cell cadherin to the actin cytoskeleton by means of a-and b-catenins.
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In EMT, tight and adherens junctions are destabilized. Zonula occludens-1 is relocated to the cytoplasm, and the expression of claudins and occludins is abrogated. E-cadherin is cleaved and degraded, 31 leaving p120-catenin free to act as transcription factors 32, 33 or to be degraded. Moreover, desmosomes and gap junctions are disrupted and, as the EMT progresses, gene expression of those proteins decreases. 34 One important epithelial cell marker known to be downregulated in EMT is E-cadherin. Loss of this cell-cell junction protein reduces the adherence with epithelial cells. Moreover, the subsequent upregulation of N-cadherin leads to an increased adherence to mesenchymal cells. This phenomenon is known as the cadherin switch. 31, 35 Due to its neuroectodermal origin, the corneal endothelium represents a special case regarding the expression of cadherins. In vivo, the contact-inhibited human corneal endothelium expresses all three cadherins (E-, N-, and VE-cadherin) but only N-and VEcadherin are properly located at the cell membrane while Ecadherin is present only in the cytoplasm. 36 It thus appears that N-cadherin and not E-cadherin plays a central role as an adherens junction protein in human CECs. Therefore, this raises the question whether N-cadherin should be used as an EndMT marker in the corneal endothelium.
Junctions also define the apical and basal compartment of polarized epithelial cells. The loss of apical-basal polarity is another characteristic found in EMT. The apical compartment is defined by the presence of partitioning-defective (PAR) and Crumbs complexes that associate with tight junctions. The basolateral compartment comprises the Scribble complexes. 37 The PAR, Crumbs, and Scribble complexes are destabilized by dissolution of tight junctions, and their expression is repressed as EMT progresses. 38 Cell isolation and subsequent passaging of CECs is inevitably associated with the dissociation of cell junctions. Success in avoiding EndMT of cultured CECs could reside in the development of culture conditions in which confluency and gain of apical-basal polarity is rapidly achieved. For example, increasing cell seeding density has been shown to diminish the occurrence of fibroblastic transformation within human CEC culture. Indeed, Peh and colleagues 39 demonstrated that a high CEC seeding density (20,000 cells/cm 2 ) resulted in more compact and contact-inhibited CECs when compared to lower cell densities (2500-5000 cells/cm 2 ), the latter resulting in a culture composed mostly of pleiomorphic fibroblastic-like cells. 39 These results replicate the comparable findings of an earlier study of primate CEC cultures. 40 
CYTOSKELETON REORGANIZATION: CHANGES IN CELL SHAPE AND MOTILITY
The EMT is also characterized by a Rho guanosine triphosphatase (Rho GTPase) family-dependent actin cytoskeleton reorganization, where RAC1 and CDC42 induce the formation of cell projections (lamelipodia and filipodia) and where RhoA is responsible for stress fiber formation. The rearrangement from an epithelial-like cortical organization to a stress fiber mesenchymal phenotype allows for an increased directional motility and contractility and leads to cell shape modification from round to elongated cells. [41] [42] [43] [44] Accordingly, Rho GTPase activity is deleterious to the apical-basal polarity. 45, 46 Cells in EMT and EndMT can express a particular form of actin, the a-smooth muscle actin (a-SMA). Alpha-smooth muscle actin is often used as an EndMT marker, in both vascular cells 47 and CECs. [48] [49] [50] The expression of a-SMA by CECs was shown to be dependent upon the addition of TGF-b, a cytokine that induces EndMT. 49 of integrins and proteases is also modified in EMT. 19 Some cells that undergo EMT can acquire ECM degradation abilities for invasion and migration, including the expression of MMPs. 19 This modulation of ECM secretion can be seen in cultured CECs. Recently, Okumura and colleagues 15 observed that cultured simian CECs that had a fibroblastic morphology expressed higher levels of fibronectin and type I and IV collagens as well as a5 and b1 integrins. In vitro models of endothelial pathologies led to the discovery of some factors implicated in the EndMT that caused abnormal ECM secretion and fibrosis by CECs. Among them, FGF-2 has been extensively studied. Corneal endothelial cells cultured with FGF-2 acquire the ability, through PI3K signaling, to stabilize type I collagen mRNA, thus leading to its secretion outside of the cell. 52 Studies on an ex vivo model of cat corneal endothelial fibrosis showed that TGF-b1-2-3 are implicated in the expression of fibronectin and a-SMA by CECs and in the loss of their endothelial phenotype. 53, 54 Addition of TGF-b1-2 to the culture medium of bovine CECs also induced the production of laminin and fibronectin in a dose-dependent manner, via TbRI and Smad2/3 and 4. 55 Corneal endothelial cells from organcultured models of retrocorneal fibrous membrane were also shown to express type I collagen and fibronectin. 56, 57 It is thus clear that cultured CECs that have undergone EndMT will not be of use in regenerative medicine. In order to control EndMT, we first need to review the current literature on signals that generate EMT. The information contained in the next paragraphs is summed up in the Figure, along with the other hallmarks of corneal EndMT discussed previously.
EXTRACELLULAR SIGNALS THAT DRIVE EMT
Among the numerous factors that trigger EMT, two types of extracellular signals and receptors were particularly studied: the transforming growth factor beta (TGF-b) superfamily (reviewed in Ref. 58 ) and the tyrosine kinase receptors. They activate many pathways that are closely related with each other.
Transforming Growth Factor-b TGF-b and the Smad Signaling Pathway. The TGF-b superfamily includes TGF-bs, bone morphogenic proteins (BMP), and activins. 59 These proteins are essential to fetal development, as they regulate genes related to developmental EMT and the reverse phenomenon, mesenchymal-to-epithelial transition (MET). They are also implicated postnatally in physiological and pathological EMT, such as in wound healing, pluripotent cell differentiation, fibrosis, and cancer (reviewed in Ref. 60). They transduce extracellular signals via transmembrane Ser/Thr kinase heterotetramer receptors and Tyr kinase receptors. The canonical pathway is activated by binding of a TGF-b protein to a type II TGF-b receptor (TbRII), a Ser/Thr kinase, which phosphorylates a type I receptor, leading to the phosphorylation of Smads.
61 Smad2 or 3 is activated by TGF-b signaling and Smad1, 5, or 8 in response to BMPs. Inhibitory Smads, namely Smad6 and 7, can compete with the latter Smads for binding to the type I receptors. 59 Smad pathways lead to activation of various transcription factors, including Snail transcription repressors, ZEB transcription factors, and basic helix-loop-helix (bHLH) factors. 62 Notably, Snail1 and 2 repress transcription of E-cadherin. 63 Snail1 is linked to disruption of the epithelial polarity 64 and remodeling of the cytoskeleton as well as cellular migration and invasion.
Likewise, Smads directly control many genes linked to the mesenchymal phenotype, like fibronectin, vimentin, and collagen a1. 58 ZEB1 and ZEB2 can repress or activate transcription, depending on the coactivators/repressors associated with FIGURE. Summary of the current knowledge on the molecular mechanisms that regulate endothelial-to-mesenchymal transition in cultured corneal endothelial cells. Multiple extracellular signals (TGF-b1-2-3, IL-1b, FGF-2, connexin 43) can influence cultured corneal endothelial cells. They act as trigger factors that can impact critical intracellular pathways (Smad, p38, Erk1/2, Wnt/b-catenin, NF-jB, p27kip1) and induce endothelial-tomesenchymal transition. On one hand, the endothelial phenotype is characterized by a contact-inhibited monolayer of polygonal-shaped cells that are arrested in the G1 phase of the cell cycle and express cell junction proteins such as ZO-1 and N-cadherin. On the other hand, cells with a fibroblastic phenotype undergo changes in cell shape, actin cytoskeleton reorganization, and disassembly of cell-cell junctions. They also lose their contact inhibition. Furthermore, they present an increased cell motility and extracellular matrix production as well as changes in gene expression. TGF, transforming growth factor; IL, interleukin; FGF, fibroblast growth factor; Erk, extracellular signal-regulated kinase; NF, nuclear factor; ZO, zonula occludens; ECM, extracellular matrix.
them. These factors repress many genes linked to the epithelial phenotype, including E-cadherin (adherens and tight junctions, epithelial polarity), activate the expression of genes associated with a mesenchymal phenotype, such as a-SMA and vimentin, and have been associated with cell migration. 58 Other extracellular signals can also lead to activation of Snails and ZEBs. Indeed, HGF, FGF, or EGF signaling by the Rasmitogen-activated protein kinase (MAPK) or PI3K-Akt pathways can cooperate with Snails in order to induce EMT. 59 It has also been shown in some cancers that Ras, 66 Notch, and Wnt 58 pathways can cooperate with TGF-b to induce Snail. Ras-MAPK and Wnt/b-catenin pathways also activate ZEB transcription factors. 62 Non-Smad Signaling by TGF-bs. Noncanonical signaling by the TGF-b family of proteins has also been linked to EMT, including extracellular signal-related kinase (Erk)-MAPK, Rho GTPases, and PI3K/Akt pathways. 58 The activation of these pathways can be done either by bonding of TGF-b to the tyrosine kinases receptors or by interaction of the phosphorylated receptors with Smads. Cooperation between Ras-Erk MAPK and the TGF-b pathways has been shown in TGF-binduced EMT, notably by downregulation of E-cadherin. [67] [68] [69] p38-MAP kinase can be activated by TGF-b to induce EMT and apoptosis. 70 It has also been demonstrated that blocking activation of p38 inhibits TGF-b-induced EMT. 
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Rho-like GTPases (Rho, Rac, Cdc42) are a Ras-related family of proteins that actively control the organization of the actin cytoskeleton. RhoA has been particularly studied in TGF-binduced EMT. When activated by TGF-b, RhoA transduces its signal to its downstream effector, ROCK, leading to formation of actin stress fibers, as discussed previously. [75] [76] [77] Furthermore, inhibition of Rho-ROCK signaling has been shown to block or reverse TGF-b-induced EMT and fibrosis in some types of cells. 76, 78 TGF-b in Human Corneal Endothelial Cells (HCECs). Human corneal endothelium expresses all three types of TGF-b receptors in vivo. 79, 80 The normal human aqueous humor contains 1.2 to 4.9 ng/mL total TGF-b 81,82 of which TGF-b2, the most abundant isoform, occupies 0.27 to 2.24 ng/mL in its inactive form and 20 to 830 pg/mL in its activated form. 83, 84 On one hand, TGF-b is mostly present in its latent form; it therefore needs to be activated in order to induce an effect upon the cells. On the other hand, human CECs also express thrombospondin-1, which is a known activator of TGF-b. [85] [86] [87] Additionally, Descemet's membrane also contains fibronectin, 88, 89 which is implicated in latent TGF-b activation. 90, 91 Considering the abundance of TGF-b in the aqueous humor, it is not surprising that this cytokine has been shown early to modulate CECs in many ways. Indeed, studies in rat and rabbit cultured endothelium showed that TGF-b2 suppresses S-phase entry, therefore leading to the loss of proliferative capabilities of CECs. [92] [93] [94] Recently, the implication of TGF-b2 in corneal endothelial wound healing was clarified by the demonstration that migration, and not proliferation, was induced by TGF-b2 in corneal endothelial wound healing models via the activation of p38. 80 These findings support previous work showing that, in ex vivo organ culture of human CECs, disruption of cell junctions by EDTA and TGF-b induced EndMT but not proliferation of the cells. 49 Globally, this reinforces the idea that TGF-b represses proliferation, and proposes that its role in the physiologic wound healing process of human corneal endothelium is based on cell migration and not proliferation. 95 Recently, Okumura et al. 15 showed that TGF-b1 generated EndMT in cultured human CECs. They also showed that in vitro, simian CECs naturally underwent EndMT following a pattern resembling the one induced by TGF-b (phosphorylation of Smad2 and p38). Contrary to the findings of Joko and colleagues, 80 they demonstrated phosphorylation of Erk1/2 by TGF-b1. 15 However, this discrepancy can be explained by the presence of FGF-2 (an Erk1/2 activator) in their growth medium, thus correlating with their peers' findings. 80 Furthermore, blocking TGF-b signaling using SB431542, a TbRI kinase activity inhibitor, allowed for CEC function-associated proteins ZO-1 and Na þ /K þ -adenosine triphosphatase (Na þ /K þ -ATPase) expression and contact-inhibited cell morphology to be maintained as well as reducing collagen I and fibronectin expression.
Interestingly, cell response to TGF-b is highly influenced by the context, which raises the concept of a duality of action known as the TGF-b paradox, commonly known to take place in invasive cancers. 96 This phenomenon describes the discrepancy between the antiproliferative effect of TGF-b and its ability to resume and deregulate proliferation in later stages of the tumoral progression. While more than a few mechanisms are thought to be implied in the TGF-b paradox, one appears particularly relevant in the context of corneal endothelial EndMT. Indeed, the TbRII serine-threonine kinase receptor also possesses a tyrosine kinase activity that introduces a wide variety of TGF-b-MAPK-associated noncanonical signaling. 97 This noncanonical signaling reveals itself to be of paramount importance in the determination of the CECs' response to TGF-b. It has been shown that TbRII possesses a tyrosine kinase activity enabling the phosphorylation of MAPK elements such as p38 or Erk1/2. 98 Moreover, the downstream specificity of this signaling seems to be governed by the expression ratio of TbRII/TbRI; a higher ratio favors Erk1/2 activation, whereas a lower ratio favors the canonical Smad signaling. 99 In order to further characterize the CECs' response to TGF-b, defining this ratio in the corneal endothelium might lead to a better targeting of TGF-b signaling.
Fibroblast Growth Factor-2
Kay and colleagues 100 were one of the first groups to have underlined a link between growth factors and changes in the CEC morphology. The first factor identified by this team as an EndMT trigger was FGF-2 (or bFGF), a growth factor known to be present within Descemet's membrane. 101, 102 They first discovered that exposure to polymorphonuclear leukocytes (PMN) led the cells to become fibroblastic-like along with causing synthesis of undegraded type I collagen in rabbit CECs.
56,100,103 They later identified IL-1b as the factor synthesized by PMN responsible in exerting such changes on CECs. 104 They also showed that this factor induced the production of FGF-2, which in the meantime had been reported to induce the same phenomenon as exposure to PMN. 102, 104, 105 Exposure to IL-1b led to the production of FGF-2 via PI3K induction of p38 by an unclear mechanism. 104, 106, 107 Recently, they showed that PI3K also allowed for the activation of NF-jB, the latter being a direct activator of FGF-2 transcription and synthesis, which underlines a preponderant role for both PI3K and NF-jB in FGF-2-induced EndMT. 108 Fibroblast growth factor-2 has been shown to stimulate the proliferation of CECs by downregulating p27 via activation of Erk1/2 by PI3K. 80, [109] [110] [111] It has also been demonstrated that FGF-2 can stabilize type I collagen a1 mRNA and thus upregulate its synthesis and secretion into the ECM by inhibiting its degradation. 112 Other Signals Wnt Signaling. Although disruption of cell junctions is usually considered to be a consequence of EMT, the case of CEC EndMT might oppose this paradigm as evidence shows this event as a potential cause of EndMT. 116, 117 Indeed, Tseng's group 49 recently unveiled a link between loss of contact inhibition by cell junction disruption and appearance of EndMT in human CECs. They showed that canonical Wnt signaling, through nuclear translocation of b-catenin following EDTAinduced cell dissociation, was directly implicated in inducing EndMT. Despite disruption of cell junctions, FGF-2 is needed to unlock the mitotic block, allowing resumption of proliferation. This effect of FGF-2 is not explained by its aforementioned EndMT-triggering capabilities per se, but by the upregulation of b-catenin it induces. 49 Indeed, overexpression of stable bcatenin suppresses the need of growth factors for EndMT to occur via disruption of cell junctions and Wnt signaling, indicating the existence of a threshold in the level of b-catenin needed to induce EndMT. Though FGF-2 activates canonical Wnt signaling by the upregulation of b-catenin protein expression, Zhu and colleagues 49 did not observe similar behavior when TGF-b was used instead of FGF-2. This may explain the absence of proliferation seen in the latter case, and it also indicates that canonical Wnt signaling is not the only pathway responsible for corneal EndMT since EDTA-TGF-btreated cultures also underwent EndMT. However, the findings suggest a way to interpret the role of proliferation in EndMT and offer an explanation for distinguishing proliferative (i.e., FGF-2), migratory (i.e., TGF-b), or mixed EndMT (i.e., FGF-2 and TGF-b).
This suggests that there would be a junctional environmentdependent effect of known EndMT-triggering factors, more specifically TGF-b. Indeed, there seems to be a relationship between the context in which CECs are exposed to EndMTtriggering factors and the actions exerted upon and within the cells. A striking case that exemplifies this concept has been shown in the study by Masszi and colleagues 116 on TGF-binduced EMT in a porcine renal proximal tubular cell line. By inducing the loss of epithelial integrity in confluent cultures, they found that the level of maturity of the cell junctions played a role in the TGF-b-induced EMT. More precisely, they showed that while TGF-b1 induced EMT in subconfluent or disrupted cultures, the cytokine did not induce EMT in confluent cultures. Though being associated with stress fiber formation, TGF-b treatment of confluent cultures did not induce a-SMA or fibronectin production or E-cadherin downregulation. By studying b-catenin implications in the phenomenon, they demonstrated that TGF-b1 treatment of subconfluent cultures protected b-catenin from degradation and allowed its signaling to take place. Once in the nucleus, bcatenin exerted a potentiating effect on the a-SMA promoter. 116, 117 Later, the same group showed that the mechanism responsible for the activation of a-SMA promoter in cells lacking contact was driven by Rho-ROCK myosin light chain (MLC) phosphorylation and cooperated with TGF-b1 signaling to enhance a-SMA expression. 117 Epidermal Growth Factor. Epidermal growth factor has been shown to enhance human CECs proliferation in vitro. 17 However, EGF is known to exert an influence in the EMT process. For example, in mammary epithelial cells, cyclooxygenase-2 (COX-2) is needed for TGF-b to induce EMT. 118, 119 However, there exists a synergy in the action of coupled COX-2 and TGF-b when EGF is present and activates the MAPK signaling. 120 This demonstrates a possible synergic role of TGFb and EGF in inducing EMT. Interestingly, COX-2 is expressed in the corneal endothelium under inflammatory conditions, 121 and its expression is induced by FGF-2. 122 Whether or not this phenomenon takes place in corneal EndMT remains to be elucidated.
Of interest, EGF was shown to induce the expression of both TWIST and SNAIL1 123, 124 and, more importantly regarding corneal EndMT, EGF can induce translocation of b-catenin to the nucleus, therefore allowing the latter to fulfill its function as a transcription regulator. 123, 125 This effect of EGF on bcatenin signaling, taken together with FGF-2 and TGF-b involvement in similar processes, seems to point toward the Wnt/b-catenin signaling as an important regulator of corneal EndMT. The precise nature and mechanisms of Wnt/b-catenin signaling in CECs should be thoroughly investigated in order to achieve a better understanding of its interaction with the other EndMT triggers.
STRATEGIES BEING DEVELOPED TO ANTAGONIZE ENDMT
In order to allow for the use of cultured human CECs in regenerative medicine, EndMT must be antagonized during EndMT
the culture process. The EndMT appears to spontaneously take place in vitro, in a variable cell population-dependent manner, and seems to be related to the induction of CEC proliferation. Thus, strategies must be developed following the pursuit of maximal CEC expansion and minimal induction of corneal EndMT. In the next paragraphs, methods currently being developed to avoid EndMT in CEC cultures will be introduced with emphasis on its application to regenerative medicine.
Inhibition of TGF-b Signaling
Since EndMT has been linked to pathway activation exerted by certain factors, the use of pathway-specific antagonists appears as a reasonable choice to inhibit undesired EndMT-induced loss of function of CECs in vitro. A recent study demonstrated the potential of SB431542, a specific TbRI (ALK5) kinase activity inhibitor, in abolishing the spontaneously occurring EndMT in in vitro human CECs. 15 The authors demonstrated that SB431542 allowed the preservation of cell shape as well as the localization of both ZO-1 and Na þ /K þ -ATPase at the cell membrane from the second to the fifth passage of cell cultivation. Finally, they showed that SB431542 decreased both fibronectin and collagen I at the mRNA level when compared to control cultures and diminished collagen I protein production.
In the same study, the authors evaluated the EndMTinhibition potential of BMP-7, another member of the TGF-b superfamily. They showed that cell shape as well as localization of both ZO-1 and Na þ /K þ -ATPase at the cell membrane was preserved in human CECs treated with BMP-7. 15 However, the mechanism of action remains unknown.
Interestingly, corneal endothelial wound healing studies in in vitro and in vivo models have shown that addition of Smad7 could block TGF-b-induced fibrosis, 126 hence showing the importance of the Smad2/3 activation in EMT/EndMT. Similar findings were obtained in the retinal pigment epithelium. 127 
Unlocking the Mitotic Block
To isolate human CECs from donor corneas, many researchers follow the method first described by Chen and colleagues, 128 which includes the stripping of Descemet's membrane followed by chemical disruption of cell junctions using EDTA and mechanical agitation. This process results in human CEC cultures exempt from stromal keratocyte contamination. This method of cell isolation, as was proposed by Tseng's team, 49 could be implicated in the induction of EndMT in vitro because of the associated Wnt signaling activation. After having uncovered the link between contact-inhibition unlocking and proliferation with EndMT, Zhu and colleagues 49 developed a way to resume human CEC proliferation in confluent explants, hence subtracting the need to disrupt cell junctions with EDTA. Indeed, they showed that treatment with p120-catenin (subsequently referred to as p120) small interfering ribonucleic acid (siRNA) resulted in reactivation of proliferation associated with conservation of a contact-inhibited phenotype. 49 Moreover, even though addition of TGF-b alone or TGF-b and FGF-2 with p120 siRNA suppressed the proliferation induced by p120 siRNA alone, p120 siRNA abolished the EndMT whether TGF-b or FGF-2 was present or not. P120 siRNA achieved this protection from EndMT by the translocation of remnant p120 protein to the nucleus, leading to the expulsion of the transcriptional repressor Kaiso from the nucleus. More importantly, this treatment did not allow b-catenin to translocate to the nucleus. Thus, p120 siRNA acts as an inhibitor of Wnt canonical pathway and consequently prevents the activation of EndMT.
The mechanism underlying the activity of p120 siRNA is related to RhoA activation since concomitant treatment with Y27632, a ROCK inhibitor, antagonized p120 siRNA-induced proliferation. Recently, it was reported that BMP noncanonical signaling was also involved in this process through demonstration of a causative link between p120 siRNA treatment and BMP2 and 4 upregulation. This led to translocation of phosphorylated (p65) NF-jB to the nucleus. 129 Finally, the translocation of p120 to the nucleus caused by p120 siRNA treatment inhibited the Hippo signaling, a pathway in contact-inhibition and organ size regulation, 130 by triggering the translocation of unphosphorylated YAP/TAZ by an unknown mechanism.
ROCK Inhibitor
In the last years, a great deal of interest has been shown in the use of a Rho/ROCK pathway inhibitor (Y27632) in order to ameliorate CEC adhesion capabilities as well as preservation of contact-inhibited cell morphology. By inhibiting the Rho pathway with Y27632 in culture, Okumura and colleagues 14 have shown that monkey CECs exhibited greater adhering capabilities, were less prone to apoptosis, and benefited from an increased proliferation. More recently, this team developed a model of postinjury rabbit and monkey CEC injection as a potential way to administer cells as a therapy. 131 In this study, they showed that injection of Y27632 with the CECs in the anterior chamber of the eye allowed for better adhesion capabilities as well as preservation of cellular morphology (otherwise compromised without the use of Y27632), leading to recovery of a contact-inhibited corneal endothelium. Additionally, this study provided evidence that nontreated injected CECs might have undergone EndMT since they expressed a-SMA; this phenomenon was not reported with the injected cells treated with Y27632. Later, the same team showed that Y27632 applied topically as 10 mM drops on monkey corneas, whose endothelium had been injured by transcorneal freeze, enhanced the rate of wound closure and promoted contact-inhibited endothelial morphology compared to fellow PBS-treated injured cornea. 132 To conclude, their work provides evidence that Y27632 might be useful in promoting survival of grafted as well as cultured CECs while maintaining contact-inhibited morphology, especially in the context of bioengineered corneal endothelial graft.
Connexin 43
Connexin43 (Cx43) is a component of CEC gap junctions. 133 It has been shown that its expression is dynamically regulated during wound healing of the rabbit corneal epithelium. 134 In an attempt to accelerate injured corneal endothelium wound closure, Nakano and colleagues 48 exploited this finding by inducing the knockdown of Cx43 in a rat corneal endothelial scrape injury. They found that Cx43 knockdown not only accelerated wound closure by inducing proliferation but also diminished the proportion of a-SMA-expressing cells, demonstrating a far less important EndMT when compared to control. They underlined that knockdown of Cx43 caused a decrease in p27kip1, a process implicated in the induction of proliferation. Despite this decreased p27kip1 expression, the general mechanism underlying the effect of Cx43 knockdown treatment remains unknown. Nonetheless, this finding seems to indicate a role played by Cx43 in corneal EndMT. 
CONCLUSIONS
It is possible to draw links between the enormous number of results that have been obtained using other cell types, as well as using CECs. While there is still some work to do in order to clarify corneal EndMT, studies conducted on the roles of some cytokines (TGF-b, FGF-2) have shown that it is possible to block many signaling pro-EndMT pathways in order to improve morphology, phenotype, and functionality of cultured CECs. The importance of cell-cell junctions in the maintenance of the endothelial phenotype is of high interest. The related activation of the Wnt/b-catenin pathway seems like a good candidate to explain many of the phenotypic events observed in in vitro CECs.
There is an increasing need to find ways to block EndMT in vitro while promoting expansion of the CECs in order to use these cells in the engineering of a functional corneal endothelium. Moreover, these studies, while providing a better understanding of the in vitro phenomenon of corneal EndMT, could eventually help in the study and the treatment of related pathological events observed in vivo.
